Adiponectin vs Glucagon

Head-to-head comparison of Adiponectin (Adiponectin (Acrp30, AdipoQ)) and Glucagon (Glucagon) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyAdiponectinGlucagon
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameAdiponectin (Acrp30, AdipoQ)Glucagon
Molecular Weight~26.4 kDa (monomer)3482.75
Half-Life~2-4 h5-10 min
Amino Acids24429
Typical DoseNo approved human dose; research use only1 mg IM/SC for severe hypoglycemia or 3 mg intranasal
RouteIV|SCIM|SC|IN|IV
Purity≥98%≥98%
Studies Count8693
Research StatusPre-clinicalApproved

Adiponectin Benefits

  • insulin sensitivity
  • fatty-acid oxidation
  • AMPK activation

Glucagon Benefits

  • rapid hypoglycemia reversal
  • raises plasma glucose
  • useful in emergency rescue

Adiponectin Dosing

not established|not established

Glucagon Dosing

1 mg IM/SC|3 mg intranasal

Adiponectin Side Effects

  • unknown
  • immunogenicity risk

Glucagon Side Effects

  • nausea
  • vomiting

Research Overview

Adiponectin

Preclinical and translational studies link adiponectin signaling with better glycemic control, lower inflammation, and improved lipid handling. Recombinant adiponectin and receptor-targeting approaches remain research tools rather than approved diabetes therapies.

Glucagon

Clinical and emergency medicine use is well established for severe hypoglycemia, with newer stable formulations improving ease of administration.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Adiponectin stacks with:

Acrp30AdipoQ

Glucagon stacks with:

glucagonGlucaGenBaqsimiGvoke
AMPKadipokineinsulin-sensitizingmetabolic-syndromediabetesmetabolicrescueglucose-regulation